Skip to main navigation Skip to search Skip to main content

Serono Pfizer # 25777 Rebif with the Addition of Tysabri Phase IV Safety Study

Project: Research

Project Details

StatusFinished
Effective start/end date06/1/0506/1/06

Funding

  • Serono Incorporated: $2,600.00